{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T13:06:28Z","timestamp":1765976788586},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,18]]},"DOI":"10.7759\/cureus.64879","type":"journal-article","created":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T06:42:25Z","timestamp":1721371345000},"source":"Crossref","is-referenced-by-count":1,"title":["CT and Fluorine-18-Fluorodeoxyglucose (18F-FDG) PET\/CT Imaging Findings of Aggressive Systemic Mastocytosis: A Case Report"],"prefix":"10.7759","author":[{"given":"Mai","family":"Sato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Kurokawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomasa","family":"Okimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junji","family":"Tokushige","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masako","family":"Ikemura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1080\/14728214.2023.2221028","article-title":"Systemic mastocytosis: 2023 update on diagnosis and management in adults","volume":"28","author":"Costa A","year":"2023","unstructured":"Costa A, Scalzulli E, Carmosino I, et al.. Systemic mastocytosis: 2023 update on diagnosis and management in adults. Expert Opin Emerg Drugs. 2023, 28:153-65. 10.1080\/14728214.2023.2221028","journal-title":"Expert Opin Emerg Drugs"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12916","article-title":"Epidemiology of systemic mastocytosis in Denmark","volume":"166","author":"Cohen SS","year":"2014","unstructured":"Cohen SS, Skovbo S, Vestergaard H, et al.. Epidemiology of systemic mastocytosis in Denmark. Br J Haematol. 2014, 166:521-8. 10.1111\/bjh.12916","journal-title":"Br J Haematol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-02-205237","article-title":"Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors","volume":"113","author":"Lim KH","year":"2009","unstructured":"Lim KH, Tefferi A, Lasho TL, et al.. Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors. Blood. 2009, 113:5727-36. 10.1182\/blood-2009-02-205237","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26962","article-title":"Systemic mastocytosis in adults: 2023 update on diagnosis, risk stratification and management","volume":"98","author":"Pardanani A","year":"2023","unstructured":"Pardanani A. Systemic mastocytosis in adults: 2023 update on diagnosis, risk stratification and management. Am J Hematol. 2023, 98:1097-116. 10.1002\/ajh.26962","journal-title":"Am J Hematol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury JD","year":"2022","unstructured":"Khoury JD, Solary E, Abla O, et al.. The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms. Leukemia. 2022, 36:1703-19. 10.1038\/s41375-022-01613-1","journal-title":"Leukemia"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus Classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber DA","year":"2022","unstructured":"Arber DA, Orazi A, Hasserjian RP, et al.. International Consensus Classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data. Blood. 2022, 140:1200-28. 10.1182\/blood.2022015850","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00256-012-1374-9","article-title":"Advanced imaging of skeletal manifestations of systemic mastocytosis","volume":"41","author":"Fritz J","year":"2012","unstructured":"Fritz J, Fishman EK, Carrino JA, Horger MS. Advanced imaging of skeletal manifestations of systemic mastocytosis. Skeletal Radiol. 2012, 41:887-97. 10.1007\/s00256-012-1374-9","journal-title":"Skeletal Radiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.iac.2018.04.013","article-title":"Bone disease in mastocytosis","volume":"38","author":"Orsolini G","year":"2018","unstructured":"Orsolini G, Viapiana O, Rossini M, Bonifacio M, Zanotti R. Bone disease in mastocytosis. Immunol Allergy Clin North Am. 2018, 38:443-54. 10.1016\/j.iac.2018.04.013","journal-title":"Immunol Allergy Clin North Am"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.176","article-title":"Increased IL6 plasma levels in indolent systemic mastocytosis patients are associated with high risk of disease progression","volume":"30","author":"Mayado A","year":"2016","unstructured":"Mayado A, Teodosio C, Garcia-Montero AC, et al.. Increased IL6 plasma levels in indolent systemic mastocytosis patients are associated with high risk of disease progression. Leukemia. 2016, 30:124-30. 10.1038\/leu.2015.176","journal-title":"Leukemia"},{"key":"ref10","article-title":"Mastocytosis presenting as a skeletal disorder","volume":"16","author":"Delsignore JL","year":"1996","unstructured":"Delsignore JL, Dvoretsky PM, Hicks DG, O'Keefe RJ, Rosier RN. Mastocytosis presenting as a skeletal disorder. Iowa Orthop J. 1996, 16:126-34.","journal-title":"Iowa Orthop J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4084\/MJHID.2021.056","article-title":"Systemic mastocytosis: radiological point of view","volume":"13","author":"Leone A","year":"2021","unstructured":"Leone A, Macagnino S, D'Ambra G, Veltri G, Perla D. Systemic mastocytosis: radiological point of view. Mediterr J Hematol Infect Dis. 2021, 13:e2021056. 10.4084\/MJHID.2021.056","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-015-3117-3","article-title":"FDG-PET\/CT findings in systemic mastocytosis: a French multicentre study","volume":"42","author":"Djelbani-Ahmed S","year":"2015","unstructured":"Djelbani-Ahmed S, Chandesris MO, Mekinian A, et al.. FDG-PET\/CT findings in systemic mastocytosis: a French multicentre study. Eur J Nucl Med Mol Imaging. 2015, 42:2013-20. 10.1007\/s00259-015-3117-3","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4103\/ijnm.ijnm_88_22","article-title":"Intense fluorodeoxyglucose uptake in aggressive systemic mastocytosis without associated hematological neoplasm: unusual fluorodeoxyglucose positron emission tomography\/computed tomography presentation","volume":"38","author":"Fatima N","year":"2023","unstructured":"Fatima N, Zaman A, Zaman S, Zaman U, Zaman MU. Intense fluorodeoxyglucose uptake in aggressive systemic mastocytosis without associated hematological neoplasm: unusual fluorodeoxyglucose positron emission tomography\/computed tomography presentation. Indian J Nucl Med. 2023, 38:65-6. 10.4103\/ijnm.ijnm_88_22","journal-title":"Indian J Nucl Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000033813","article-title":"Aggressive systemic mastocytosis of colon and lymph node: a case report","volume":"102","author":"Xun-Ze S","year":"2023","unstructured":"Xun-Ze S, Liu F, Lin C, Sun YF. Aggressive systemic mastocytosis of colon and lymph node: a case report. Medicine (Baltimore). 2023, 102:e33813. 10.1097\/MD.0000000000033813","journal-title":"Medicine (Baltimore)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.202.2.9015059","article-title":"Systemic mastocytosis: CT and US features of abdominal manifestations","volume":"202","author":"Avila NA","year":"1997","unstructured":"Avila NA, Ling A, Worobec AS, Mican JM, Metcalfe DD. Systemic mastocytosis: CT and US features of abdominal manifestations. Radiology. 1997, 202:367-72. 10.1148\/radiology.202.2.9015059","journal-title":"Radiology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.179.5.1791235","article-title":"FDG positron emission tomography in patients with systemic mastocytosis","volume":"179","author":"Zettinig G","year":"2002","unstructured":"Zettinig G, Becherer A, Szabo M, Uffmann M, Dudczak R, Valent P, Kletter K. FDG positron emission tomography in patients with systemic mastocytosis. AJR Am J Roentgenol. 2002, 179:1235-7. 10.2214\/ajr.179.5.1791235","journal-title":"AJR Am J Roentgenol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000028651","article-title":"A case of systemic mastocytosis mimicking POEMS syndrome: a case report","volume":"101","author":"Hou Y","year":"2022","unstructured":"Hou Y, Jiang S, Zhang L, et al.. A case of systemic mastocytosis mimicking POEMS syndrome: a case report. Medicine (Baltimore). 2022, 101:e28651. 10.1097\/MD.0000000000028651","journal-title":"Medicine (Baltimore)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-020-06919-1","article-title":"Computed tomography findings of early-stage TAFRO syndrome and associated adrenal abnormalities","volume":"30","author":"Kurokawa R","year":"2020","unstructured":"Kurokawa R, Gonoi W, Yokota H, et al.. Computed tomography findings of early-stage TAFRO syndrome and associated adrenal abnormalities. Eur Radiol. 2020, 30:5588-98. 10.1007\/s00330-020-06919-1","journal-title":"Eur Radiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12040837","article-title":"Radiological imaging findings of adrenal abnormalities in TAFRO syndrome: a systematic review","volume":"12","author":"Kurokawa R","year":"2024","unstructured":"Kurokawa R, Baba A, Kano R, Kaneko Y, Kurokawa M, Gonoi W, Abe O. Radiological imaging findings of adrenal abnormalities in TAFRO syndrome: a systematic review. Biomedicines. 2024, 12:837. 10.3390\/biomedicines12040837","journal-title":"Biomedicines"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/273878-ct-and-fluorine-18-fluorodeoxyglucose-18f-fdg-petct-imaging-findings-of-aggressive-systemic-mastocytosis-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T06:42:28Z","timestamp":1721371348000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/273878-ct-and-fluorine-18-fluorodeoxyglucose-18f-fdg-petct-imaging-findings-of-aggressive-systemic-mastocytosis-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,18]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.64879","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,18]]}}}